A citation-based method for searching scientific literature

Rhodé M Bijlsma, Annelien L Bredenoord, Christa G Gadellaa-Hooijdonk, Martijn Pj Lolkema, Stefan Sleijfer, Emile E Voest, Margreet Gem Ausems, Neeltje Steeghs. Eur J Hum Genet 2016
Times Cited: 18







List of co-cited articles
49 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
38

Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics.
Carla G van El, Martina C Cornel, Pascal Borry, Ros J Hastings, Florence Fellmann, Shirley V Hodgson, Heidi C Howard, Anne Cambon-Thomsen, Bartha M Knoppers, Hanne Meijers-Heijboer,[...]. Eur J Hum Genet 2013
203
27

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
799
27

Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing.
Kelly Hitch, Galen Joseph, Jenna Guiltinan, Jessica Kianmahd, Janey Youngblom, Amie Blanco. J Genet Couns 2014
45
22

Next Generation DNA Sequencing: Always Allow an Opt Out.
Annelien L Bredenoord, Rhodé M Bijlsma, Hans van Delden. Am J Bioeth 2015
8
50

Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy.
Annelien L Bredenoord, N Charlotte Onland-Moret, Johannes J M Van Delden. Hum Mutat 2011
87
22

Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology.
Martijn P Lolkema, Christa G Gadellaa-van Hooijdonk, Annelien L Bredenoord, Peter Kapitein, Nancy Roach, Edwin Cuppen, Nine V Knoers, Emile E Voest. J Clin Oncol 2013
62
22


Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics.
Carla G van El, Martina C Cornel, Pascal Borry, Ros J Hastings, Florence Fellmann, Shirley V Hodgson, Heidi C Howard, Anne Cambon-Thomsen, Bartha M Knoppers, Hanne Meijers-Heijboer,[...]. Eur J Hum Genet 2013
81
16

Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study.
Flavia M Facio, Haley Eidem, Tyler Fisher, Stephanie Brooks, Amy Linn, Kimberly A Kaphingst, Leslie G Biesecker, Barbara B Biesecker. Eur J Hum Genet 2013
122
16

Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Marco Gerlinger, Andrew J Rowan, Stuart Horswell, M Math, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart,[...]. N Engl J Med 2012
16

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Fiona A Miller, Robin Z Hayeems, Jessica P Bytautas, Philippe L Bedard, Scott Ernst, Hal Hirte, Sebastien Hotte, Amit Oza, Albiruni Razak, Stephen Welch,[...]. Eur J Hum Genet 2014
59
16


To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts.
Gabrielle M Christenhusz, Koenraad Devriendt, Kris Dierickx. Eur J Hum Genet 2013
105
16

Scanning the body, sequencing the genome: Dealing with unsolicited findings.
Roel H P Wouters, Candice Cornelis, Ainsley J Newson, Eline M Bunnik, Annelien L Bredenoord. Bioethics 2017
10
30

Towards a European consensus for reporting incidental findings during clinical NGS testing.
Jayne Y Hehir-Kwa, Mireille Claustres, Ros J Hastings, Conny van Ravenswaaij-Arts, Gabrielle Christenhusz, Maurizio Genuardi, Béla Melegh, Anne Cambon-Thomsen, Philippos Patsalis, Joris Vermeesch,[...]. Eur J Hum Genet 2015
57
16

Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics.
Tessel Rigter, Lidewij Henneman, Ulf Kristoffersson, Alison Hall, Helger G Yntema, Pascal Borry, Holger Tönnies, Quinten Waisfisz, Mariet W Elting, Wybo J Dondorp,[...]. Hum Mutat 2013
39
16


Genomic inheritances: disclosing individual research results from whole-exome sequencing to deceased participants' relatives.
Ben Chan, Flavia M Facio, Haley Eidem, Sara Chandros Hull, Leslie G Biesecker, Benjamin E Berkman. Am J Bioeth 2012
43
11

A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
M Dietel, K Jöhrens, M V Laffert, M Hummel, H Bläker, B M Pfitzner, A Lehmann, C Denkert, S Darb-Esfahani, D Lenze,[...]. Cancer Gene Ther 2015
83
11

Mutational landscape and significance across 12 major cancer types.
Cyriac Kandoth, Michael D McLellan, Fabio Vandin, Kai Ye, Beifang Niu, Charles Lu, Mingchao Xie, Qunyuan Zhang, Joshua F McMichael, Matthew A Wyczalkowski,[...]. Nature 2013
11

Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment.
Joost S Vermaat, Isaac J Nijman, Marco J Koudijs, Frank L Gerritse, Stefan J Scherer, Michal Mokry, Wijnand M Roessingh, Nico Lansu, Ewart de Bruijn, Richard van Hillegersberg,[...]. Clin Cancer Res 2012
115
11

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
11

Research ethics and the challenge of whole-genome sequencing.
Amy L McGuire, Timothy Caulfield, Mildred K Cho. Nat Rev Genet 2008
141
11

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Paul B Chapman, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio,[...]. N Engl J Med 2011
11


89Zr-cetuximab PET imaging in patients with advanced colorectal cancer.
Catharina Willemien Menke-van der Houven van Oordt, Elske C Gootjes, Marc C Huisman, Danielle J Vugts, Chantal Roth, Anne Marije Luik, Emma R Mulder, Robert C Schuit, Ronald Boellaard, Otto S Hoekstra,[...]. Oncotarget 2015
63
11

Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.
Anna Middleton, Katherine I Morley, Eugene Bragin, Helen V Firth, Matthew E Hurles, Caroline F Wright, Michael Parker. Eur J Hum Genet 2016
110
11


Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing.
Layla Shahmirzadi, Elizabeth C Chao, Erika Palmaer, Melissa C Parra, Sha Tang, Kelly D Farwell Gonzalez. Genet Med 2014
73
11

Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
Michael P Mackley, Benjamin Fletcher, Michael Parker, Hugh Watkins, Elizabeth Ormondroyd. Genet Med 2017
67
11

Preferences for results delivery from exome sequencing/genome sequencing.
Martha F Wright, Katie L Lewis, Tyler C Fisher, Gillian W Hooker, Toby E Emanuel, Leslie G Biesecker, Barbara B Biesecker. Genet Med 2014
43
11

Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age.
K A Kaphingst, J Ivanovich, B B Biesecker, R Dresser, J Seo, L G Dressler, P J Goodfellow, M S Goodman. Clin Genet 2016
27
11

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Stacy W Gray, Elyse R Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth Bair, Joshua Gagne, Judy Garber, Pasi A Jänne, Neal Lindeman,[...]. Genet Med 2016
68
11

Research participants in NGS studies want to know about incidental findings.
Anne Marie Jelsig, Niels Qvist, Klaus Brusgaard, Lilian Bomme Ousager. Eur J Hum Genet 2015
21
11


Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Himisha Beltran, Kenneth Eng, Juan Miguel Mosquera, Alexandros Sigaras, Alessandro Romanel, Hanna Rennert, Myriam Kossai, Chantal Pauli, Bishoy Faltas, Jacqueline Fontugne,[...]. JAMA Oncol 2015
181
11

Physicians' attitudes about multiplex tumor genomic testing.
Stacy W Gray, Katherine Hicks-Courant, Angel Cronin, Barrett J Rollins, Jane C Weeks. J Clin Oncol 2014
137
11

Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape.
D J Vis, J Lewin, R G Liao, M Mao, F Andre, R L Ward, F Calvo, B T Teh, A A Camargo, B M Knoppers,[...]. Ann Oncol 2017
12
16


Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
11

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
296
11

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, Meera Prasad, Michael Walsh, Ahmet Zehir, Ai Ni, Tinu Thomas, Ryma Benayed, Asad Ashraf,[...]. JAMA Oncol 2016
161
11

Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing.
Rhodé M Bijlsma, Hester Wessels, Roel H P Wouters, Anne M May, Margreet G E M Ausems, Emile E Voest, Annelien L Bredenoord. Fam Cancer 2018
9
22

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F Walsh, Yirong Li,[...]. JAMA 2017
185
11

Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL.
Zandra C Deans, Jose Luis Costa, Ian Cree, Els Dequeker, Anders Edsjö, Shirley Henderson, Michael Hummel, Marjolijn Jl Ligtenberg, Marco Loddo, Jose Carlos Machado,[...]. Virchows Arch 2017
52
11

Patient preferences regarding incidental genomic findings discovered during tumor profiling.
Melinda L Yushak, Gang Han, Sara Bouberhan, Lianne Epstein, Michael P DiGiovanna, Sarah S Mougalian, Tara B Sanft, Maysa M Abu-Khalaf, Gina G Chung, Stacey M Stein,[...]. Cancer 2016
29
11

Managing incidental findings in human subjects research: analysis and recommendations.
Susan M Wolf, Frances P Lawrenz, Charles A Nelson, Jeffrey P Kahn, Mildred K Cho, Ellen Wright Clayton, Joel G Fletcher, Michael K Georgieff, Dale Hammerschmidt, Kathy Hudson,[...]. J Law Med Ethics 2008
458
11

The incidentalome: a threat to genomic medicine.
Isaac S Kohane, Daniel R Masys, Russ B Altman. JAMA 2006
213
11

CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record.
Brian H Shirts, Joseph S Salama, Samuel J Aronson, Wendy K Chung, Stacy W Gray, Lucia A Hindorff, Gail P Jarvik, Sharon E Plon, Elena M Stoffel, Peter Z Tarczy-Hornoch,[...]. J Am Med Inform Assoc 2015
56
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.